Status:
RECRUITING
A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.
Lead Sponsor:
Shengjing Hospital
Conditions:
Pulmonary Embolism and Thrombosis
Deterioration, Clinical
Eligibility:
All Genders
18+ years
Brief Summary
This study collected clinical, laboratory, and CT parameters of acute patients with acute pulmonary embolism from admission to predict adverse outcomes within 30 days after admission into hospital.
Detailed Description
This study collected clinical, laboratory, and CT parameters of acute patients with acute pulmonary embolism from admission. The outcomes of interest were defined as the occurrence of adverse outcomes...
Eligibility Criteria
Inclusion Criteria:
- age of ≥ 18 years and a PE diagnosis based on CT pulmonary angiography
Exclusion Criteria:
- pregnancy
- reception of reperfusion treatment before admission
- missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I), and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels.
Key Trial Info
Start Date :
January 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05098769
Start Date
January 18 2021
End Date
December 31 2026
Last Update
March 11 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shenjing Hospital of CHINA MEDICAL UNIVERSITY
Shenyang, Liaoning, China